[ Price : $8.95]
FDA asks the Oncologic Drugs Advisory Committee to advise whether GSKs Votrient should be approved, given questions about its safe...[ Price : $8.95]
Addrenex Pharmaceuticals submits an sNDA to FDA for Clonicel to treat attention deficit hyperactivity disorder.[ Price : $8.95]
FDA announces changes in heparin manufacturing controls mandated by USP that will cause a drop in drug potency with clinical impli...[ Price : $8.95]
FDA says Penumbra has recalled its original version of the Neuron 6F 070 Delivery Catheter due to reports that it could kink in ce...[ Price : $8.95]
FDA asks the Oncologic Drugs Advisory Committee whether the benefit of Scherings PegIntron in providing some relapse-free survival...[ Price : $8.95]
The Center for Science in the Public Interest sues Bayer for refusing to remove all ad claims for Mens One A Day multivitamins cla...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes postmarketing safety reporting requirements for combination products.[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for AstraZenecas Cleviprex for the purpose of patent extensio...